By Notice dated June 8, 2005, and published in the Federal Register on June 15, 2005, (70 FR 34796), Boehringer Ingelheim Chemical Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in Schedules II:
|Methadone Intermediate (9254)||II|
|Dextropropoxyphene, bulk (non-dosage forms) (9273)||II|
The company plans to manufacture the listed controlled substances for formulation into finished pharmaceuticals. Subsequent to the Notice of Application, being published in the Federal Register on June 15, 2005, Boehringer Ingelheim Chemical Inc., requested the surrender of drug code Levo-alphacetylmethadol (9648) from their registration.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemical Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Boehringer Ingelheim Chemical Inc., to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed.Start Signature
Dated: November 18, 2005.
Joseph T. Rannazzisi,
Acting Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E5-8082 Filed 12-28-05; 8:45 am]
BILLING CODE 4410-09-P